Sanara MedTech Inc. stock is up 17.28% since 30 days ago. The next earnings date is Mar 18, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 24.14% of the previous 32 November’s closed higher than October. 100% of analysts rate it a buy.
Sanara MedTech Inc. develops, markets, and distributes wound and skin care products. It offers CellerateRX Surgical Activated Collagen powder and gel that are used in a range of surgical specialties. The company also provides HYCOL Hydrolyzed Collagen Powder and Gel for the management of full and partial thickness wounds.